Medico Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE630Y01024
  • NSEID: MEDICO
  • BSEID: 540937
INR
40.35
1.25 (3.2%)
BSENSE

Mar 13

BSE+NSE Vol: 3.81 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Medico Remedies
Zenotech Lab.
Trident Lifeline
Amanta Healthcar
Albert David
Everest Organics
Medicamen Biotec
Valiant Laborato
Zim Laboratories
Solara Active PP
Infinium Pharma

Why is Medico Remedies Ltd ?

1
High Management Efficiency with a high ROCE of 15.04%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.89 times
3
The company has declared Positive results for the last 4 consecutive quarters
  • PAT(Latest six months) At Rs 5.44 cr has Grown at 30.46%
  • ROCE(HY) Highest at 20.65%
  • PBT LESS OI(Q) At Rs 3.15 cr has Grown at 52.17%
4
With ROCE of 15.8, it has a Fair valuation with a 4.3 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -29.21%, its profits have risen by 31.1% ; the PEG ratio of the company is 0.9
5
Majority shareholders : Promoters
6
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -29.21% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Medico Remedies should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Medico Remedies for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Medico Remedies
-29.21%
-0.54
53.97%
Sensex
1.0%
0.08
12.13%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
9.66%
EBIT Growth (5y)
30.00%
EBIT to Interest (avg)
8.58
Debt to EBITDA (avg)
1.08
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
2.30
Tax Ratio
24.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.49%
ROCE (avg)
15.69%
ROE (avg)
17.20%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
28
Industry P/E
33
Price to Book Value
4.86
EV to EBIT
24.88
EV to EBITDA
20.28
EV to Capital Employed
4.32
EV to Sales
1.76
PEG Ratio
0.90
Dividend Yield
NA
ROCE (Latest)
15.85%
ROE (Latest)
17.35%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
PAT(Latest six months)

At Rs 5.44 cr has Grown at 30.46%

ROCE(HY)

Highest at 20.65%

PBT LESS OI(Q)

At Rs 3.15 cr has Grown at 52.17%

DEBTORS TURNOVER RATIO(HY)

Highest at 2.99 times

NET SALES(Q)

Highest at Rs 58.68 cr

-2What is not working for the Company
INVENTORY TURNOVER RATIO(HY)

Lowest at 4.15 times

Loading Valuation Snapshot...

Here's what is working for Medico Remedies

Net Sales - Quarterly
At Rs 58.68 cr has Grown at 48.59%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 3.15 cr has Grown at 52.17%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Latest six months
At Rs 5.44 cr has Grown at 30.46%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 58.68 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Debtors Turnover Ratio- Half Yearly
Highest at 2.99 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Medico Remedies

Inventory Turnover Ratio- Half Yearly
Lowest at 4.15 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio